	US 11,986,458 B1
	Natural and synthetic andrographolides compounds for the treatment of skeletal muscular dystrophies
Juan O. Hancke, Valdivia (CL); Enrique Brandan, Santiago (CL); and Daniel Cabrera, Santiago (CL)
Assigned to HP Ingredients Corp., Bradenton, FL (US)
Filed by Innobiosciences LLC, Bradenton, FL (US)
Filed on May 11, 2018, as Appl. No. 15/976,898.
Int. Cl. A61K 31/365 (2006.01); A61K 9/00 (2006.01); A61P 21/00 (2006.01)

CPC A61K 31/365 (2013.01) [A61K 9/0053 (2013.01); A61P 21/00 (2018.01)]

18 Claims

1. A method comprising: diagnosing Duchenne or Becker's muscular dystrophy in a human, and then providing to the human an oral formulation of andrographolide, said oral formulation including an amount of ardrographolide effective to maintain healthy function in the human or treat at least one symptom of Duchenne or Becker's muscular dystrophy.